Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inholtra Line Extensions, Price Roll Back Promoted In $2 Mil. Ad Campaign

This article was originally published in The Tan Sheet

Executive Summary

Irwin Naturals/4Health is extending its Inholtra natural joint pain relief formula franchise with two new dietary supplements - InholtraNow topical cream and Inholtra SulfaMax MSM formula. The products will begin shipping to health food and mass market outlets in mid-August.

You may also be interested in...



Omni Voluntarily Modifies Inholtra Ads Following NAD Review

Future ads for Omni Nutraceuticals' Inholtra Natural Pain Formula combination supplement will limit content comparisons to other glucosamine-containing products, the company agrees in NAD's recently released June Case Reports.

Omni Voluntarily Modifies Inholtra Ads Following NAD Review

Future ads for Omni Nutraceuticals' Inholtra Natural Pain Formula combination supplement will limit content comparisons to other glucosamine-containing products, the company agrees in NAD's recently released June Case Reports.

Omni Voluntarily Modifies Inholtra Ads Following NAD Review

Future ads for Omni Nutraceuticals' Inholtra Natural Pain Formula combination supplement will limit content comparisons to other glucosamine-containing products, the company agrees in NAD's recently released June Case Reports.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090110

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel